Pharmaceuticals sector

India to tackle global obesity with cheap, Ozempic knock-off jabs

Semaglutide is the active ingredient in weight-loss drugs such as Ozempic and Wegovy.

News analysis

Middle East war disrupts pharma air routes, threatening cancer and other drugs’ supply

A photograph shows Doha's skyline on March 10, 2026. The oil-rich Gulf has borne the brunt of Iran's attacks in response to US-Israeli strikes that sparked the Middle East war, with Tehran targeting US assets but also civilian infrastructure, including energy facilities and airports. (Photo by AFP) / Attention editors: AFP covers the war in the Middle East through its extensive regional network, including bureaus in Tehran, Jerusalem, and several neighboring countries. Since the start of the conflict, journalists have been working under increasingly restrictive conditions. Authorities in several countries have limited reporters' movements, photo and live video coverage from sensitive locations. Some governments and armed groups have banned images of missile or drone strikes and other security-related sites. /

Singapore still subject to 10% US tariff as no official word yet on higher 15% rate: Gan Siow Huang

The Government is ready to roll out further measures to support business and workers if needed, said Ms Gan Siow Huang, Minister of State for Trade and Industry.

Moderna agrees to pay up to $2.87 billion to settle Covid-19 vaccine patent dispute

The deal resolves all US and international legal actions accusing Moderna of using lipid nanoparticle without permission in its Covid-19 vaccine.

News analysis

S’pore retains lowest-tariff edge in Asia even as US court ruling narrows the gap

Trade-oriented economies like Singapore will be supported by any pickup in trade activity on lower tariffs.

Bayer proposes $9.16 billion plan to settle Roundup cancer cases

Bayer acquired Roundup as part of its US$63 billion purchase of agrochemical company Monsanto in 2018.

China charges former AstraZeneca regional head Leon Wang

Families in China scramble for mercury thermometers ahead of ban despite health risks

The ban applies to manufacturing, not to owning or selling existing inventory.

Singapore lifts 2026 growth forecast to 2%-4% on AI outlook after economy outperforms in 2025

The forecast was upgraded after the Singapore economy grew 6.9 per cent in the final quarter of 2025, much better than expected.

S’pore to focus on remaining ‘top of mind’ for Asia-bound firms amid global uncertainty: EDB

EDB managing director Jermaine Loy said Singapore’s role goes beyond serving as a regional base.

E-paper

Newsletters

Podcasts

RSS Feed

About Us

Terms & Conditions

Personal Data Protection Notice

Need help? Reach us here.

Advertise with us

MDDI (P) 046/10/2025. Published by SPH Media Limited, Co. Regn. No.202120748H. Copyright © 2026 SPH Media Limited. All rights reserved.